Where health
meets clarity.
Evidence first
We cut through the noise with reporting grounded in science, regulatory filings, and on-the-record sources.
News that matters
From FDA decisions to GLP-1 breakthroughs, we track the stories shaping tomorrow’s healthcare landscape.
Global lens
Beyond the beltway — we cover Europe, Asia, and emerging markets with the same rigor.
Born from a biotech readout.
United HealthCare started as a simple newsletter in a Boston coffee shop — three science writers tired of
press releases that said nothing. We wanted the real story: the failures,
the funding rounds, the late-night FDA emails.
Today, our domain united-healthcare.online is read by clinicians, investors, and policy nerds
in 47 countries. We’ve grown, but we still obsess over the same things: transparency, context, and
a healthy skepticism. Our team includes a former hospital pharmacist, a data journalist, and a
recovering biotech equity analyst.
You’ll find us covering everything from Definium’s LSD therapy to GLP-1s in children,
always with an eye on what it means for patients and the future of care.
The humans behind the headlines
- Dr. Elena Voss — Lead biotech reporter, former clinical pharmacist (Johns Hopkins).
- Marcus Chen — Data & policy editor. Previously at STAT News and a health-tech startup.
- Priya Nair — Regulatory correspondent. Covers FDA, EMA, and global access.
- Samir Okoye — Features writer. Specializes in public health and equity.
Offbeat & on‑brand
- Fuel: 23 gallons of cold brew per month (team consensus).
- Office dog: “Roche” — a golden retriever who attends every editorial meeting.
- First story ever: “FDA’s quiet rehiring crisis” (still relevant today).
- Most cited newsletter: The Readout — our daily digest.
#FDA
#GLP-1
#Medicare
#AstraZeneca
#HealthPolicy
anyone else connects the dots. Their coverage of the FDA pilot program and DOGE delays was essential reading.”
— Dr. L. Moreno, health policy advisor